Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 50 to 70

Helping osteoarthritis patients walk with NSAIDs

Official title: A Rehabilitation Walking Program With the Help of a Transient Intake of Nonsteroidal Anti-inflammatory Drug for Patients With Painful Hip/Knee Osteoarthritis - A Pilot Cohort Study With Objectives of Short Walks in the Real Life.

Run by University Hospital, Clermont-Ferrand · NCT05761015 · Data updated 2026-11-12

This study is testing a new program that combines special exercises and occasional use of pain relief medications to help people with hip or knee osteoarthritis walk better.

Quick facts

PhasePhase 4
Study typeInterventional
Ages50 Years to 70 Years
SexAll
Enrollment55 (estimated)
SponsorUniversity Hospital, Clermont-Ferrand
Academic / other
Locations1 site (Clermont-Ferrand)
StatusRecruiting
StartedDecember 14, 2023
Main results expectedApril 2028
Study endsApril 2028
Registry record updatedFebruary 27, 2026
Trial IDNCT05761015 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with unilateral or bilateral hip or knee osteoarthritis experiencing moderate pain while walking.

Probably not a fit

Patients with secondary osteoarthritis or those unable to walk without support devices may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to improve walking ability in patients with painful hip or knee osteoarthritis through a multimodal rehabilitation program combined with intermittent use of nonsteroidal anti-inflammatory drugs (NSAIDs). The study involves a single-center, non-randomized, open-label design where participants will undergo assessments and interventions over a 12-week period. Patients will receive tailored footwear, education on managing pain and side effects, and will track their pain and activity levels throughout the study. The goal is to optimize pain relief while minimizing the risks associated with continuous NSAID use.

Why it matters

Potential benefit: If successful, this approach could significantly enhance the quality of life for osteoarthritis patients by improving their ability to walk with reduced pain.

How similar studies have gone: While the use of NSAIDs in osteoarthritis management is common, this specific multimodal approach is novel and has not been extensively tested in previous studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Uni- or bilateral hip or knee idiopathic osteoarthrosis (ACR criteria, Kellgren-Lawrence grade 2 or more on recent X-ray), responsible for pain since 3 at least months, and pain at walking which intensity is at least 4/10 on a numerical rating scale.
* Less than 3 relevant walks (at least 20 minutes or 1000 km) a week.
* Ability to understand and to follow the protocol, and to answer the questionnaires

Exclusion Criteria:

* Pregnancy or breastfeeding
* Legal protection
* Body weight \< 40 kg or underweight
* Body weight \>120 kg or obesity
* Unability to walk, or unability to walk without support devices (sticks, crutches, orthoses and knee pads are allowed)
* Secondary osteoarthrosis (rheumatism, septic arthritis, recent osteonecrosis, hemochromatosis, gout, acromegalia…).
* Concomitant general bone disease (Paget, Reiter…).
* Concomitant and relevant painful disease else than due to osteoarthrosis (e.g. neuropathic pain, fibromyalgia…)
* Previous recent intervention (e.g. surgery, arthroscopy, joint infiltration) expected to relief osteoarthrosis pain throughout the study period.
* Planned intervention similar to those abovementioned, during the study period.
* Recent initiation of any new analgesic treatment (including systemic steroids).
* Planned initiation of any program expected to relief osteoarthrosis pain during the study period, such as physiotherapy, cognitive behavioral therapy…).
* Planned major surgery during the study period.
* Current cancer disease.
* Immunosuppression.
* Autoimmune disease.
* Concomitant topical or systemic NSAID treatment.
* Chronic strong opioid intake.
* Concomitant insulin therapy.
* Any absolute or relevant contraindication to NSAIDs or acetaminophen, according to the French drug agency

Where it's running

  • CHU Clemront-Ferrand
    Clermont-Ferrand, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.